Ana Gomes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ana Gomes has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Cláudia Afonso
Division of Aquaculture, Upgrading and Bioprospection (DivAV), Portuguese Institute for the Sea and Atmosphere (IPMA, I.P.), Av. Alfredo Magalhães Ramalho, 6, 1495-165 Algés, Portugal
11 shared publications - Carlos Cardoso
Division of Aquaculture, Upgrading and Bioprospection (DivAV), Portuguese Institute for the Sea and Atmosphere (IPMA, I.P.), Av. Alfredo Magalhães Ramalho, 6, 1495-165 Algés, Portugal
10 shared publications - Luisa Cristina Roseiro
UEISTSA—Unidade Estratégica de Investigação e Serviços de Tecnologia e Segurança Alimentar, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), 2780-157 Oeiras, Portugal
9 shared publications - Miguel Elias
MED (Mediterranean Institute for Agriculture, Environment and Development), CHANGE—Global Change and Sustainability Institute, IIFA (Instituto de Investigação e Formação Avançada), Universidade de Évora, Pólo da Mitra, Ap. 94, 7002-554 Évora, Portugal
7 shared publications - Carlos Santos
INIAV Campus do IAPMEI, Edificio S Estrada do Paço do Lumiar, 22 1649-038 Lisboa
6 shared publications - Narcisa Maria Bandarra
IPMA—Portuguese Institute for Sea and Atmosphere, 1495-006 Lisboa, Portugal
6 shared publications
Latest Publications
- Open Access
- 3 June 2026
- Published by MDPI AG in Marine Drugs
- Vol. 24 (6) , 197
Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects
Due to its high prevalence and significant impact on modern society, Alzheimer’s disease (AD) is one of the most important neurodegenerative disorders. It is more common among individuals over the age of 65, and its incidence has increased sharply as a result of rising life expectancy. Several factors have made it challenging to identify an effective treatment for AD. One major difficulty lies in its complexity, as the mechanisms involved in its progression are not yet fully understood. Nevertheless, the role of diet and lipids has been highlighted by numerous studies, underscoring their potential influence on this pathology. Due to the intricacy of its biochemical and metabolic interactions, this subject continues to be of particular interest, highlighting the need for further research. In this sense, this comprehensive and updated review aimed to elucidate these aspects, especially regarding marine-derived lipids, whose bioactive potential may become an irreplaceable tool in the management of AD, whether in terms of its treatment or prevention.
- 3 June 2026
- Published by MDPI AG in Marine Drugs
- Vol. 24 (6) , 197
Open AccessMarine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects
Due to its high prevalence and significant impact on modern society, Alzheimer’s disease (AD) is one of the most important neurodegenerative disorders. It is more common among individuals over the age of 65, and its incidence has increased sharply as a result of rising life expectancy. Several factors have made it challenging to identify an effective treatment for AD. One major difficulty lies in its complexity, as the mechanisms involved in its progression are not yet fully understood. Nevertheless, the role of diet and lipids has been highlighted by numerous studies, underscoring their potential influence on this pathology. Due to the intricacy of its biochemical and metabolic interactions, this subject continues to be of particular interest, highlighting the need for further research. In this sense, this comprehensive and updated review aimed to elucidate these aspects, especially regarding marine-derived lipids, whose bioactive potential may become an irreplaceable tool in the management of AD, whether in terms of its treatment or prevention.
- Open Access
- 14 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (8) , 1164
Neuronal Count, Brain Injury, and Sustained Cognitive Function in 5×FAD Alzheimer’s Disease Mice Fed DHA-Enriched Diets
Alzheimer’s disease (AD) is the most common form of dementia, affecting over 50 million people globally. Since 1906, efforts to understand this neurodegenerative disease and to develop effective treatments have continued to this day. Recognizing docosahexaenoic acid (DHA, 22:6n-3) as a safe, inexpensive and vital nutrient for brain health and cognitive protection due to its key role in brain development and function, this study explores novel, sustainable non-fish sources as potential dietary supplements to prevent or mitigate AD, within a blue biotechnology framework. Forty 5×FAD male mice, five weeks old, were allocated to five body weight-matched dietary groups (n = 8) and fed isocaloric diets based on AIN-93M standard chow for 6 months. Each diet, except the control feed (non-supplemented group), enclosed a modified lipid fraction supplemented with 2% of the following: (1) linseed oil (LSO, rich in alpha-linolenic acid (ALA,18:3n-3)); (2) cod liver oil (fish oil, FO, rich in both DHA and eicosapentaenoic acid (EPA, 20:5n-3)); (3) Schizochytrium sp. microalga oil (Schizo) with 40% of DHA; and (4) commercial DHASCO oil (DHASCO) with 70% of DHA. The different diets did not affect (p > 0.05) growth performance criteria (e.g., final body weight, daily feed intake, and body weight gain) suggesting no effect on the overall caloric balance or mice growth, but n-3 long-chain polyunsaturated-fatty acid (n-3 LCPUFA) supplementation significantly reduced total cholesterol (p < 0.001) and total lipids (p < 0.001). No systemic inflammation was detected in 5×FAD mice. In parallel, a beneficial modulation of lipid metabolism by DHA-enriched diets was observed, with polyunsaturated fatty acid incorporation, particularly DHA, across key metabolic tissues, such as the liver (p < 0.001) and the brain (p < 0.001). No behavioural variations were detected using an open-field test after 6 months of diet (p > 0.05). While mice fed a standard diet or LSO diet showed cognitive deficit, the incorporation of FO, Schizo or DHASCO oils into dietary routine showed promising protective effects on the working memory (p < 0.05) and the last two diets also on the recognition memory (p < 0.05) Increased neuronal count (p < 0.05), reflecting neuronal survival, was clearly observed with the fish oil diet. In turn, the number of TAU-positive cells (p < 0.05) was reduced in the Schizo diet, while β-amyloid deposition (p < 0.01) and the neuroinflammatory marker, IBA1 (p < 0.05), were decreased across all DHA-enriched diets. These promising findings open new avenues for further studies focused on the protective effects of DHA derived from sustainable and underexploited Schizochytrium sp. microalga in the prevention of AD.
- 14 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (8) , 1164
Open AccessNeuronal Count, Brain Injury, and Sustained Cognitive Function in 5×FAD Alzheimer’s Disease Mice Fed DHA-Enriched Diets
Alzheimer’s disease (AD) is the most common form of dementia, affecting over 50 million people globally. Since 1906, efforts to understand this neurodegenerative disease and to develop effective treatments have continued to this day. Recognizing docosahexaenoic acid (DHA, 22:6n-3) as a safe, inexpensive and vital nutrient for brain health and cognitive protection due to its key role in brain development and function, this study explores novel, sustainable non-fish sources as potential dietary supplements to prevent or mitigate AD, within a blue biotechnology framework. Forty 5×FAD male mice, five weeks old, were allocated to five body weight-matched dietary groups (n = 8) and fed isocaloric diets based on AIN-93M standard chow for 6 months. Each diet, except the control feed (non-supplemented group), enclosed a modified lipid fraction supplemented with 2% of the following: (1) linseed oil (LSO, rich in alpha-linolenic acid (ALA,18:3n-3)); (2) cod liver oil (fish oil, FO, rich in both DHA and eicosapentaenoic acid (EPA, 20:5n-3)); (3) Schizochytrium sp. microalga oil (Schizo) with 40% of DHA; and (4) commercial DHASCO oil (DHASCO) with 70% of DHA. The different diets did not affect (p > 0.05) growth performance criteria (e.g., final body weight, daily feed intake, and body weight gain) suggesting no effect on the overall caloric balance or mice growth, but n-3 long-chain polyunsaturated-fatty acid (n-3 LCPUFA) supplementation significantly reduced total cholesterol (p < 0.001) and total lipids (p < 0.001). No systemic inflammation was detected in 5×FAD mice. In parallel, a beneficial modulation of lipid metabolism by DHA-enriched diets was observed, with polyunsaturated fatty acid incorporation, particularly DHA, across key metabolic tissues, such as the liver (p < 0.001) and the brain (p < 0.001). No behavioural variations were detected using an open-field test after 6 months of diet (p > 0.05). While mice fed a standard diet or LSO diet showed cognitive deficit, the incorporation of FO, Schizo or DHASCO oils into dietary routine showed promising protective effects on the working memory (p < 0.05) and the last two diets also on the recognition memory (p < 0.05) Increased neuronal count (p < 0.05), reflecting neuronal survival, was clearly observed with the fish oil diet. In turn, the number of TAU-positive cells (p < 0.05) was reduced in the Schizo diet, while β-amyloid deposition (p < 0.01) and the neuroinflammatory marker, IBA1 (p < 0.05), were decreased across all DHA-enriched diets. These promising findings open new avenues for further studies focused on the protective effects of DHA derived from sustainable and underexploited Schizochytrium sp. microalga in the prevention of AD.
- Open Access
- 23 January 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (3) , 1129
Portuguese Traditional Dry-Fermented Sausages Processed with Liquid Smoke Flavoring: How This Alternative Technology Affects Proteolysis and Biogenic Amines Profile
To avoid carcinogenic polycyclic aromatic hydrocarbons, liquid smoke flavoring (LSF) is widely used by the meat industry, yet wood smoking remains a deep-rooted practice among Portuguese traditional dry-fermented producers. In this study, the use of LSF was compared with traditional smoking. In addition, two different ways of using LSF were also tested: spraying and mixing (during seasoning). The profiles of amino acids (AA) and biogenic amines (BA) were studied at pre-scheduled moments of processing and storage. When compared to smoked products, LSF did not affect total AA content; however, when mixed during seasoning, it inhibited the accumulation of arginine and lysine (precursors of BA) in final products. The conventional smoking replacement, by mixing LSF during seasoning, turned out to be critical to lessen BA of bacterial origin accumulation as well, especially for putrescine, cadaverine and tyramine. The benefits of spraying LSF over smoking were higher for final products than for storage, as differences between them tended to fade with time (except for tyramine). These results also demonstrate that a simple change in traditional dry-fermented sausage processing, such as mixing LSF during product seasoning, significantly contributes to the safety of these products through the reduction in undesirable BA.
- 23 January 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (3) , 1129
Open AccessPortuguese Traditional Dry-Fermented Sausages Processed with Liquid Smoke Flavoring: How This Alternative Technology Affects Proteolysis and Biogenic Amines Profile
To avoid carcinogenic polycyclic aromatic hydrocarbons, liquid smoke flavoring (LSF) is widely used by the meat industry, yet wood smoking remains a deep-rooted practice among Portuguese traditional dry-fermented producers. In this study, the use of LSF was compared with traditional smoking. In addition, two different ways of using LSF were also tested: spraying and mixing (during seasoning). The profiles of amino acids (AA) and biogenic amines (BA) were studied at pre-scheduled moments of processing and storage. When compared to smoked products, LSF did not affect total AA content; however, when mixed during seasoning, it inhibited the accumulation of arginine and lysine (precursors of BA) in final products. The conventional smoking replacement, by mixing LSF during seasoning, turned out to be critical to lessen BA of bacterial origin accumulation as well, especially for putrescine, cadaverine and tyramine. The benefits of spraying LSF over smoking were higher for final products than for storage, as differences between them tended to fade with time (except for tyramine). These results also demonstrate that a simple change in traditional dry-fermented sausage processing, such as mixing LSF during product seasoning, significantly contributes to the safety of these products through the reduction in undesirable BA.
- Open Access
- 29 February 2024
- Published by MDPI AG in Marine Drugs
- Vol. 22 (3) , 116
New Forms of Neuroactive Phospholipids for DHA Enrichment in Brain
Low levels of docosahexaenoic acid (DHA) in the brain have been related to neurological disorders, like Alzheimer’s disease (AD). After ingestion, dietary DHA must cross the blood–brain barrier, where it is absorbed as lysophosphatidylcholine (LPC), due to its role as a preferential DHA carrier in the brain. This work aimed at the production of LPC-DHA extracts to be used in supplementation/food fortification intended neural enrichment in DHA. As it is rich in DHA, especially its phospholipids (PL), Atlantic mackerel (Scomber scombrus, caught in Spring/2022) was used as a raw material. The polar lipids fraction was separated and hydrolysed with Rhizomucor miehei lipase, to enzymatically convert phosphatidylcholine (PC) into LPC. The fish (muscle and by-products) lipids fraction was used for total lipids (TL) content, lipid classes (LC) and fatty acid (FA) profile evaluation, whilst polar lipids extracts were studied for LC production and FA analysis. Muscle TL ranged between 1.45 and 4.64 g/100 g (WW), while by-products accounted for 7.56-8.96 g/100 g, with the highest contents being found in March. However, PL were more abundant in muscle (22.46–32.20% of TL). For polar lipids extracts, PL represented 50.79% of TL, among which PC corresponded to 57.76% and phosphatidylethanolamine to 42.24%. After hydrolysis, nearly half of this PC was converted into LPC. When compared to the initial PC, DHA relative content (33.6% of total FA) was significantly higher after hydrolysis: 55.6% in PC and 73.6% in LPC. Such extract, obtained from this undervalued species, may represent a promising strategy to increase DHA uptake into brain cells while allowing this species to upgrade.
- 29 February 2024
- Published by MDPI AG in Marine Drugs
- Vol. 22 (3) , 116
Open AccessNew Forms of Neuroactive Phospholipids for DHA Enrichment in Brain
Low levels of docosahexaenoic acid (DHA) in the brain have been related to neurological disorders, like Alzheimer’s disease (AD). After ingestion, dietary DHA must cross the blood–brain barrier, where it is absorbed as lysophosphatidylcholine (LPC), due to its role as a preferential DHA carrier in the brain. This work aimed at the production of LPC-DHA extracts to be used in supplementation/food fortification intended neural enrichment in DHA. As it is rich in DHA, especially its phospholipids (PL), Atlantic mackerel (Scomber scombrus, caught in Spring/2022) was used as a raw material. The polar lipids fraction was separated and hydrolysed with Rhizomucor miehei lipase, to enzymatically convert phosphatidylcholine (PC) into LPC. The fish (muscle and by-products) lipids fraction was used for total lipids (TL) content, lipid classes (LC) and fatty acid (FA) profile evaluation, whilst polar lipids extracts were studied for LC production and FA analysis. Muscle TL ranged between 1.45 and 4.64 g/100 g (WW), while by-products accounted for 7.56-8.96 g/100 g, with the highest contents being found in March. However, PL were more abundant in muscle (22.46–32.20% of TL). For polar lipids extracts, PL represented 50.79% of TL, among which PC corresponded to 57.76% and phosphatidylethanolamine to 42.24%. After hydrolysis, nearly half of this PC was converted into LPC. When compared to the initial PC, DHA relative content (33.6% of total FA) was significantly higher after hydrolysis: 55.6% in PC and 73.6% in LPC. Such extract, obtained from this undervalued species, may represent a promising strategy to increase DHA uptake into brain cells while allowing this species to upgrade.
- 13 September 2021
- Published by Taylor & Francis in Journal of Aquatic Food Product Technology
- Vol. 30 (9) , 1189-1203
Key Constituents and Antioxidant Activity of Novel Functional Foods Developed withSkeletonemaSp. Biomass
A recently isolated microalgal strain of Skeletonema sp. (Skt) has shown relevant bioactivities. Novel functional foods incorporating this strain were studied: a 3%, w/w, Skeletonema cookie (Skt Ck) and a 2%, w/w, Skeletonema sauce (Skt Sc), which were compared with a control cookie (Ctl Ck) and a control sauce (Ctl Sc), respectively. The fatty acid (FA) profile of the microalgal biomass was characterized by a large share of saturated FA, followed by monounsaturated FA and polyunsaturated FA (PUFA). Within PUFA, omega-3 PUFA exceeded n6 PUFA (omega-3/omega-6 ratio of 12.7 ± 1.1). The microalgal profile was dominated by the 14:0 and 16:1 FAs. The addition of Skeletonema sp. biomass increased 14:0 and 16:1 FAs contents in the products. The incorporation of Skeletonema sp. biomass led to a higher phenolic content in Skt Sc. Microalgal inclusion in the cookies reduced bioaccessibility in most cases. Skt Sc showed a larger functional food potential.
- 13 September 2021
- Published by Taylor & Francis in Journal of Aquatic Food Product Technology
- Vol. 30 (9) , 1189-1203
Key Constituents and Antioxidant Activity of Novel Functional Foods Developed withSkeletonemaSp. Biomass
A recently isolated microalgal strain of Skeletonema sp. (Skt) has shown relevant bioactivities. Novel functional foods incorporating this strain were studied: a 3%, w/w, Skeletonema cookie (Skt Ck) and a 2%, w/w, Skeletonema sauce (Skt Sc), which were compared with a control cookie (Ctl Ck) and a control sauce (Ctl Sc), respectively. The fatty acid (FA) profile of the microalgal biomass was characterized by a large share of saturated FA, followed by monounsaturated FA and polyunsaturated FA (PUFA). Within PUFA, omega-3 PUFA exceeded n6 PUFA (omega-3/omega-6 ratio of 12.7 ± 1.1). The microalgal profile was dominated by the 14:0 and 16:1 FAs. The addition of Skeletonema sp. biomass increased 14:0 and 16:1 FAs contents in the products. The incorporation of Skeletonema sp. biomass led to a higher phenolic content in Skt Sc. Microalgal inclusion in the cookies reduced bioaccessibility in most cases. Skt Sc showed a larger functional food potential.
- 26 July 2021
- Published by Wiley in Phycological Research
- Vol. 69 (4) , 246-257
The effect of drying on undervalued brown and red seaweed species: Bioactivity alterations
SUMMARY: The effect of drying on two brown seaweed (Treptacantha abies‐marina and Cystoseira humilis) and two red seaweed species (Asparagopsis armata and Asparagopsis taxiformis) was evaluated based on the levels of biological activity, such as antioxidant and anti‐inflammatory properties. Moreover, the contents of some significant compound classes, such as polyphenols and beta‐glucans, were determined. Seaweeds C. humilis and T. abies‐marina showed high polyphenol levels (1.76–6.78 mg gallic acid equivalents g−1 dw), which clearly exceeded those determined in the Asparagopsis genus regardless of drying process. This was partially reflected in the antioxidant activity as measured by DPPH and FRAP methods, which showed that extracts from C. humilis and T. abies‐marina in most cases had stronger antioxidant activity than those from Asparagopsis species. The influence of the drying technique upon the antioxidant activity was relatively limited, since in many instances there was no effect. Concerning anti‐inflammatory activity, in the case of shade‐dried samples, C. humilis had a higher activity (>30% COX‐2 inhibition) than A. armata. However, this activity in C. humilis was not rendered available in the upper gastrointestinal (GI) tract. Indeed, only A. taxiformis displayed anti‐inflammatory activity in the fraction available in the upper GI tract, showing an upper GI tract availability in the 90–100% range. Therefore, though bioactivity levels were higher in C. humilis and T. abies‐marina, Asparagopsis species also had substantial levels of bioactive compound. Sun‐drying produced more negative effects than shade‐drying, but these effects were not very extensive.
- 26 July 2021
- Published by Wiley in Phycological Research
- Vol. 69 (4) , 246-257
The effect of drying on undervalued brown and red seaweed species: Bioactivity alterations
SUMMARY: The effect of drying on two brown seaweed (Treptacantha abies‐marina and Cystoseira humilis) and two red seaweed species (Asparagopsis armata and Asparagopsis taxiformis) was evaluated based on the levels of biological activity, such as antioxidant and anti‐inflammatory properties. Moreover, the contents of some significant compound classes, such as polyphenols and beta‐glucans, were determined. Seaweeds C. humilis and T. abies‐marina showed high polyphenol levels (1.76–6.78 mg gallic acid equivalents g−1 dw), which clearly exceeded those determined in the Asparagopsis genus regardless of drying process. This was partially reflected in the antioxidant activity as measured by DPPH and FRAP methods, which showed that extracts from C. humilis and T. abies‐marina in most cases had stronger antioxidant activity than those from Asparagopsis species. The influence of the drying technique upon the antioxidant activity was relatively limited, since in many instances there was no effect. Concerning anti‐inflammatory activity, in the case of shade‐dried samples, C. humilis had a higher activity (>30% COX‐2 inhibition) than A. armata. However, this activity in C. humilis was not rendered available in the upper gastrointestinal (GI) tract. Indeed, only A. taxiformis displayed anti‐inflammatory activity in the fraction available in the upper GI tract, showing an upper GI tract availability in the 90–100% range. Therefore, though bioactivity levels were higher in C. humilis and T. abies‐marina, Asparagopsis species also had substantial levels of bioactive compound. Sun‐drying produced more negative effects than shade‐drying, but these effects were not very extensive.
- 19 October 2020
- Published by Taylor & Francis in Journal of Aquatic Food Product Technology
- Vol. 29 (10) , 964-980
Treptacantha abies-marina(S.G. Gmelin) Kützing: Characterization and Application as a Whole Food Ingredient
The brown seaweed Treptacantha abies-marina is an abundant resource still undervalued. Novel products incorporating this seaweed were prepared: a 3%, w/w, Treptacantha abies-marina cookie (Tpc Ck) and a 2%, w/w, Treptacantha abies-marina sauce (Tpc Sc), which were compared with a control cookie (Ctl Ck) and a control sauce (Ctl Sc), respectively. The proximate composition, elemental composition, and phenolic content as well as the antioxidant activity, as measured by 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and Ferric Ion Reducing Antioxidant Power (FRAP) methods, of the used seaweed and control and Tpc-enriched nutraceutical products were determined. The bioaccessibility was assessed through an in vitro digestive model. Sauces and cookies differed in their elemental composition, being K, Ca, Mg, Na, P, and Zn concentrations higher in the sauces. The addition of seaweed biomass affected the As concentration, which increased from 4.8 ± 0.7 to 40.4 ± 2.7 mg/kg dw and from 3.7 ± 0.2 to 15.9 ± 1.3 mg/kg dw, for sauces and cookies, respectively. On the basis of FRAP and ABTS, sauces, and especially Tpc Sc, yielded aqueous extracts more antioxidant than the cookies. Antioxidant activity enhancement by seaweed incorporation was stronger in the cookies. Elemental bioaccessibility was high, 100% for Ca, Mg, and Na.
- 19 October 2020
- Published by Taylor & Francis in Journal of Aquatic Food Product Technology
- Vol. 29 (10) , 964-980
Treptacantha abies-marina(S.G. Gmelin) Kützing: Characterization and Application as a Whole Food Ingredient
The brown seaweed Treptacantha abies-marina is an abundant resource still undervalued. Novel products incorporating this seaweed were prepared: a 3%, w/w, Treptacantha abies-marina cookie (Tpc Ck) and a 2%, w/w, Treptacantha abies-marina sauce (Tpc Sc), which were compared with a control cookie (Ctl Ck) and a control sauce (Ctl Sc), respectively. The proximate composition, elemental composition, and phenolic content as well as the antioxidant activity, as measured by 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and Ferric Ion Reducing Antioxidant Power (FRAP) methods, of the used seaweed and control and Tpc-enriched nutraceutical products were determined. The bioaccessibility was assessed through an in vitro digestive model. Sauces and cookies differed in their elemental composition, being K, Ca, Mg, Na, P, and Zn concentrations higher in the sauces. The addition of seaweed biomass affected the As concentration, which increased from 4.8 ± 0.7 to 40.4 ± 2.7 mg/kg dw and from 3.7 ± 0.2 to 15.9 ± 1.3 mg/kg dw, for sauces and cookies, respectively. On the basis of FRAP and ABTS, sauces, and especially Tpc Sc, yielded aqueous extracts more antioxidant than the cookies. Antioxidant activity enhancement by seaweed incorporation was stronger in the cookies. Elemental bioaccessibility was high, 100% for Ca, Mg, and Na.
- 18 September 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (11) , 9721-9728
The development of a novel functional food: bioactive lipids in yogurts enriched withAurantiochytriumsp. biomass
Western diets are poor in healthy n3 polyunsaturated fatty acids, such as docosahexaenoic acid. Since microalga Aurantiochytrium sp. is rich in docosahexaenoic acid, a functional food based on lean yogurt and this microalga was tested. This study entailed characterizing the lipid fraction and determining the fatty acid bioaccessibility. The tested yogurts (control and 2% w/w, Aurantiochytrium sp.) had differences. Docosahexaenoic acid was not detected in the control product, but it was the second most important fatty acid in Aurantiochytrium sp. and Aurantiochytrium yogurt, 29.7 ± 0.4% and 18.7 ± 2.0%, respectively. Based on the fatty acid profile only, an amount of 158.7 g of Aurantiochytrium yogurt in wet weight terms would be required to ensure an appropriate intake of healthy fatty acids. Generally, the fatty acid bioaccessibility was not high, remaining below 60–70% in almost all cases. Considering the docosahexaenoic acid bioaccessibility (44 ± 3%), an amount of 360.7 g of Aurantiochytrium yogurt would be advisable. A reasonable dietary prescription would be a daily consumption of 125 ml of Aurantiochytrium yogurt.
- 18 September 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (11) , 9721-9728
The development of a novel functional food: bioactive lipids in yogurts enriched withAurantiochytriumsp. biomass
Western diets are poor in healthy n3 polyunsaturated fatty acids, such as docosahexaenoic acid. Since microalga Aurantiochytrium sp. is rich in docosahexaenoic acid, a functional food based on lean yogurt and this microalga was tested. This study entailed characterizing the lipid fraction and determining the fatty acid bioaccessibility. The tested yogurts (control and 2% w/w, Aurantiochytrium sp.) had differences. Docosahexaenoic acid was not detected in the control product, but it was the second most important fatty acid in Aurantiochytrium sp. and Aurantiochytrium yogurt, 29.7 ± 0.4% and 18.7 ± 2.0%, respectively. Based on the fatty acid profile only, an amount of 158.7 g of Aurantiochytrium yogurt in wet weight terms would be required to ensure an appropriate intake of healthy fatty acids. Generally, the fatty acid bioaccessibility was not high, remaining below 60–70% in almost all cases. Considering the docosahexaenoic acid bioaccessibility (44 ± 3%), an amount of 360.7 g of Aurantiochytrium yogurt would be advisable. A reasonable dietary prescription would be a daily consumption of 125 ml of Aurantiochytrium yogurt.